Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and v3.4.0 was removed from the page.
    Difference
    0.1%
    Check dated 2026-02-05T17:12:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new Revision: v3.3.4 is added and the previous Revision: v3.3.3 is removed.
    Difference
    0.1%
    Check dated 2026-01-15T04:48:55.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A new Locations section appears with Texas as a site, replacing the earlier Texas Locations entry; the HHS Vulnerability Disclosure link is removed.
    Difference
    0.2%
    Check dated 2025-12-24T14:46:21.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Publications section wording updated to replace 'the study results' with 'the results of the study' and to add a version tag (Revision: v3.3.2) while removing the older tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:51:44.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The government funding and operating status notice has been removed from the page, while core study details, eligibility criteria, and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:30:01.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    No significant changes detected in the page contents or structure between screenshots; the primary study details remain the same.
    Difference
    0.4%
    Check dated 2025-10-27T21:11:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.